Wadmann, Sarah (Author)
Amalie Martinus Hauge (Author)
Personalized medicine raises the stakes of pharmaceutical market regulation. Drawing on pragmatist valuation studies and science and technology studies literature on personalized medicine and pharmaceutical markets, this article demonstrates how complex negotiations about the value of a pharmaceutical can constitute a market in various ways, while also shaping the concerned patient populations. Tracing the path of a pharmacogenetic treatment, Spinraza, from its approval by the European Medicines Agency to its adoption in the publicly funded Danish healthcare system, we show how the market was formatted through particular stratifications of the patient population. We conceptualize these seemingly technical moves as strategies of stratification, that is, the application of techniques to assemble and divide data – and what data are meant to represent – into groups delineated by certain characteristics. We argue that stakeholders’ use of strategies of stratification has important implications not only for market access, but also for the delineation of diseases and patient populations. Hence, it is crucial to make intelligible the mutual constitution of pharmaceutical markets and patient populations and the political efforts of delineating and connecting the two.
...More
Article
Colleen Lanier-Christensen;
(September 2021)
Creating Regulatory Harmony: The Participatory Politics of OECD Chemical Testing Standards in the Making
(/isis/citation/CBB606231580/)
Article
Klaus Hoeyer;
(July 2015)
Regulatory Anatomy: How “Safety Logics” Structure European Transplant Medicine
(/isis/citation/CBB387324455/)
Article
Alison Cool;
(August 2019)
Impossible, unknowable, accountable: Dramas and dilemmas of data law
(/isis/citation/CBB709306750/)
Article
Judy Z Segal;
(August 2018)
Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’
(/isis/citation/CBB311917478/)
Article
Angela N. H. Creager;
(September 2021)
To Test or Not to Test: Tools, Rules, and Corporate Data in US Chemicals Regulation
(/isis/citation/CBB745420064/)
Article
Kahn, Jonathan;
(2008)
Exploiting Race in Drug Development: BiDil's Interim Model of Pharmacogenomics
(/isis/citation/CBB000953517/)
Article
Kristrún Gunnarsdóttir;
Kjetil Rommetveit;
(2017)
The Biometric Imaginary: (dis)trust in a Policy Vacuum
(/isis/citation/CBB939896615/)
Article
Phillip H. Roth;
Tommaso Bruni;
(2022)
Participation, Empowerment, and Evidence in the Current Discourse on Personalized Medicine: A Critique of “Democratizing Healthcare”
(/isis/citation/CBB677774404/)
Article
Jonas Rüppel;
(2019)
“Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research
(/isis/citation/CBB269148677/)
Book
Shirley Hsiao-Li Sun;
(2017)
Socio-economics of Personalized Medicine in Asia
(/isis/citation/CBB224387222/)
Article
Schwabl, Herbert;
(2013)
The Mercury Puzzle: Tibetan Medicines and the Pharmaceutical Regulations in the European Union--Assessments and Opportunities
(/isis/citation/CBB001510480/)
Article
Brian Salter;
(January 2022)
Markets, Cultures, and the Politics of Value: The Case of Assisted Reproductive Technology
(/isis/citation/CBB380652953/)
Article
Consuelo Uribe-Mallarino;
(2022)
Collaborating as peers or targeted by science diplomacy? The participation of Latin American researchers in the European Framework Programme for Research and Innovation
(/isis/citation/CBB459784661/)
Article
Marjolein Lanzing;
Elisa Lievevrouw;
Lotje Siffels;
(2022)
It Takes Two to Techno-Tango: An Analysis of a Close Embrace Between Google/Apple and the EU in Fighting the Pandemic Through Contact Tracing Apps
(/isis/citation/CBB332952770/)
Article
Anja Bauer;
Alexander Bogner;
(2020)
Let’s (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues
(/isis/citation/CBB333309152/)
Article
Stephens, Neil;
Atkinson, Paul;
Glasner, Peter;
(December 2011)
Documenting the doable and doing the documented: Bridging strategies at the UK Stem Cell Bank
(/isis/citation/CBB128580755/)
Article
Ignace Schoot;
Charles Mather;
(2022)
Opening Up Containment
(/isis/citation/CBB238068628/)
Article
Christy Spackman;
Gary A. Burlingame;
(June 2018)
Sensory politics: The tug-of-war between potability and palatability in municipal water production
(/isis/citation/CBB215070697/)
Article
Oliver Todt;
José Luis Luján;
(2022)
Rationality in Context: Regulatory Science and the Best Scientific Method
(/isis/citation/CBB425178130/)
Article
Christopher L. Cummings;
Agnes S. F. Chuah;
Shirley S. Ho;
(September 2018)
Protection Motivation and Communication through Nanofood Labels: Improving Predictive Capabilities of Attitudes and Purchase Intentions toward Nanofoods
(/isis/citation/CBB867911612/)
Be the first to comment!